Transcript Highlights:

• and babies, including the PRAMS, the Pregnancy Risk Assessment Monitoring System, tobacco data from FDA
• system tobacco assessment monitoring system tobacco data<00:59:42.079> from<00:59:42.319> FDA
• <00:59:42.960> center<00:59:43.200> for<00:59:43.359> tobacco data from FDA
• center for tobacco data from FDA center for tobacco products<00:59:44.880> and<00:59:45.359>

Keywords: 912, senate, all

Summary: The Judiciary Committee held an informational briefing on the State of Hawaii’s affirmative litigation against the federal administration, with no public testimony. Attorney General Lopez and deputies said the office’s goal is to enforce the rule of law, not make partisan points, and noted that Hawaii is involved in 27 ongoing cases. They grouped the cases into four broad areas: immigration, funding freezes and grant terminations, federal agency dismantling/reductions in force, and protecting elections, health, and safety. Several immigration-related cases were discussed in detail. These included a challenge to the federal sharing of Medicaid data with DHS for immigration enforcement, a similar challenge to USDA’s demand for SNAP applicant and recipient data, and litigation over immigration-enforcement conditions attached to federal grants. The office also described the birthright citizenship executive order, saying it conflicts with the 14th Amendment and Supreme Court precedent; lower courts granted preliminary relief, and the U.S. Supreme Court later addressed only the scope of nationwide injunctions, not the merits. In the Department of Transportation case, the court granted a preliminary injunction against the “Duffy directive,” finding the immigration conditions lacked statutory authority, were arbitrary and capricious, and violated the Spending Clause and APA. The briefing also covered multiple funding disputes. In the education funding freeze case, the Department of Education and OMB withheld about $6 billion in formula funds, including roughly $33 million for Hawaii; after suit was filed, the funds were released. Other cases included the termination of over $11 billion in public health grants, which affected Hawaii Department of Health grants, the NIH indirect cost cap case, and NIH grant terminations tied to DEI, transgender issues, and vaccine hesitancy. The speakers said some cases have already resulted in preliminary or permanent injunctions, while others remain on appeal or are still being litigated.

Transcript Highlights:

• We are working on a large letter going to Secretary Kennedy, the FDA, and the EPA.
• 23:03.760> Secretary<01:23:04.400> Kennedy,<01:23:05.199> the<01:23:05.360> FDA
• ,<01:23:05.920> and<01:23:06.159> the to Secretary Kennedy, the FDA, and the to Secretary
• Kennedy, the FDA, and the EPA.<01:23:07.360> And<01:23:07.760> bipartisan<01:23:08.480

Keywords: 1187, senate, all

Transcript Highlights:

• EpiPens or epinephrine injectors and replaces it with an epinephrine delivery system, basically an FDA-approved
• > epinephrine delivery system, basically epinephrine delivery system, basically an<00:10:39.519> FDA
• <00:10:40.079> approved<00:10:40.880> single<00:10:41.519> pre-measured an FDA
• approved single pre-measured an FDA approved single pre-measured dose.<00:10:43.120> This<00:

Keywords: 1183, house

Transcript Highlights:

• of a primary care doctor who has any knowledge of the disease to only 5% of rare diseases having any FDA-approved
• 00:05:15.280> diseases<00:05:16.080> having<00:05:16.400> any<00:05:16.680> FDA
• <00:05:17.360> approved rare diseases having any FDA approved rare diseases having any FDA

Keywords: 1183, house

Transcript Highlights:

• accreditation is not required for patients treated in qualified CAR T-cell centers that follow strict FDA
• And they must provide coverage at a qualified health care facility that meets FDA regulations.

Bills: SB801, SB867, SB2717, SB2919, HJR7, HB4, HB14, HB27, HB42, HB46, HB100, HB111, HB112, HB121, HB126, HB146, HB186, HB223, HB229, HB322, HB367, HB500, HB521, HB640, HB705, HB783, HB1052, HB1056, HB1105, HB1106, HB1178, HB1211, HB1234, HB1306, HB1403, HB1449, HB1506, HB1661, HB1690, HB1871, HB1960, HB2017, HB2078, HB2128, HB2240, HB2243, HB2348, HB2407, HB2512, HB2820, HB2844, HB2853, HB2854, HB2885, HB3000, HB3005, HB3053, HB3057, HB3181, HB3333, HB3372, HB3425, HB3441, HB3516, HB3749, HB3783, HB3812, HB3848, HB3923, HB3963, HB4070, HB4134, HB4157, HB4158, HB4211, HB4449, HB4623, HB4638, HB4687, HB4690, HB4748, HB4749, HB4795, HB4848, HB5093, HB5115, HB5129, HB5138, HB5294, HB5616, HB5629, HB5646, HB5661, HB5672, HB5674, HB5699, HCR40, SJR5, SJR27, SJR59, SB4, SB6, SB8, SB9, SB10, SB12, SB22, SB23, SB25, SB27, SB34, SB36, SB37, SB38, SB40, SB57, SB140, SB261, SB293, SB441, SB447, SB467, SB512, SB650, SB777, SB785, SB924, SB1188, SB1281, SB1318, SB1333, SB1398, SB1448, SB1566, SB1579, SB1621, SB1723, SB1838, SB1862, SB2167, SB2405, SB2406, SB2407, SB2878, SB3059, SB3070, SB1, SB17, SB21, SB260, SB379, SB509, SB1198, SB1405, SB1506, SB1637, SB1833, SB2155, SB2308, SB2601, SB2778, HB300, HB2011, HB2525, HB5246, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3045, SB3071, HJR7, HB5115, HB3053, HB1403, HB223, HB748, HB5652, HB3395, HB180, HB1306, HB322, HB126, HB5650, HB4894, HB1629, HB5698, HB3171, HB2694, HB5664, HB4690, HB4464, HB3623, HB2520, HB2213, HB252, HB146, HB5596, HB3619, HB5320, HB5651, HB5670, HB5665, HB5437, HB5679, HB5699, HB5661, HB5662, HB5654, HB5672, HB5656, HB3812, HB3057, HB2035, HB721, HB346, HB2512, HB5695, HB5694, HB5674, HB3185, HB2348, HB1871, HB1135, HB101, HB5666, HB5677, HB5682, HB5658, HB4144, HB3642, HB3815, HB2686, HB2012, HB1960, HB227, HB654, HB1690, HB2128, HB4158, HB4630, HB1523, HB2078, HB1973, HB3333, HB3697, HB3546, HB3225, HB3181, HB2820, HB1506, HB1234, HB640, HB521, HB229, HB186, HB119, HB4795, HB4466, HB3749, HB1106, HB4, HB4170, HB3909, HB4081, HB4145, HB4157, HB4285, HB4463, HB4995, HB5138, HB5624, HB1449, HB2598, HB3629, HB4361, HB824, HB1868, HB4848, HB2243, HB40, HB117, HB3686, HB500, HB3793, HB112, HB104, HB1056, HB42, HB3000, HB100, HB2240, HB718, HB27, HB4904, HB4202, HB2853, HB5129, HB5093, HB4765, HB4748, HB4559, HB4350, HB4214, HB3388, HB3112, HB5196, HB4211, HB3516, HB3092, HB4233, HB4687, HB705, HB1094, HB2037, HB3005, HB3848, HB1105, HB121, HB3372, HB367, HB783, HB3336, HB3441, HB4449, HB5616, HB2407, HB2854, HB3425, HB5294, HB1178, HB4623, HB14, HB3963, HB1211, HB5646, HB5629, HB3783, HB4236, HB46, HB4638, HB1052, HB4070, HB5509, HB5435, HB4134, HB3923, HB3520, HB3320, HB2517, HB2488, HB5663, HB2731, HB3073, HB2655, HB2399, HB541, HB4099, HB111, HB1532, HB3483, HB2963, HB4580, HB3748, HB713, HB632, HB426, HB4730, HB127, HB5690, HB5689, HB5655, HB3385, HB2757, HB4359, HB5381, HB20, HB123, HB549, HB5606, HB2217, HB2594, HB796, HB150, HB1057, HCR141, HCR40, HCR59, HCR76, HCR81, HCR46, HCR111, HCR83, HCR84, HJR7, HB4, HB14, HB27, HB42, HB46, HB100, HB126, HB150, HB322, HB367, HB500, HB640, HB705, HB783, HB1105, HB1178, HB1211, HB1234, HB1506, HB1690, HB1871, HB2078, HB2128, HB2240, HB2243, HB2407, HB2512, HB2853, HB2854, HB3000, HB3057, HB3181, HB3372, HB3425, HB3441, HB3749, HB3783, HB3812, HB3923, HB3963, HB4070, HB4134, HB4157, HB4211, HB4449, HB4623, HB4638, HB4687, HB4748, HB4795, HB5093, HB5129, HB5616, HB5629, HB5699, HB229, HB521, HB1056, HB1106, HB5138, SR583, SCR52, HB223, HB229, HB521, HB1056, HB1106, HB1403, HB3053, HB5115, HB5138

Keywords: SB 801, birth certificate, birth record, certified copy, homeless, homelessness, unhoused, vital records, state registrar, local registrar, county clerk, fee waiver, identity documents, ID access, housing insecurity, shelter, transitional housing, Health and Safety Code, HHSC, Health and Human Services Commission

Transcript Highlights:

• Food and Drug Administration, the FDA.
• vaccine or drug that is experimental or investigational or under emergency use authorization by the FDA

Bills: SB227, SB269, SB407, SB463, SB527, SB547, SB1283, SB1380, SB1383, SB1511, SB1640, SB1784, SB2069

Keywords: school funding, education reform, state budget, property taxes, equity in education, healthcare policy, vaccines, exemptions, religious beliefs, public health, workplace violence, healthcare facilities, definition expansion, safety regulations, health and safety code, health insurance, anesthesia, pediatric dental services, coverage, medical necessity

Summary: The Senate Committee on Health and Human Services met with several members initially absent, then later established a quorum. The committee heard multiple bills, with most testimony focusing on access to care, insurance practices, senior safety, and health care worker protections. Several bills were laid out with committee substitutes, and public testimony was limited to two minutes per witness. Most bills were left pending after testimony, with no final votes taken in the portion provided. Senate Bill 2069 would create a work group to study the feasibility of a statewide acute psychiatric bed registry; the substitute shifts appointment authority to the Health and Human Services Commissioner and extends reporting and sunset dates. Senate Bill 463 would expand workplace violence protections to additional hospice, home and community support, intermediate care, and state-supported living center settings. Senate Bill 1283 would require background checks and transparency measures for senior retirement communities after testimony about the Dallas-area serial killings of elderly residents. Senate Bill 1784 would require 60 days’ written notice before medical debt is sent to collections. Senate Bill 527 would require medical insurance coverage for general anesthesia for medically necessary pediatric dental procedures for children under 13 with qualifying conditions; pediatric dentists testified that denials delay needed care. A major portion of the meeting centered on prior authorization. Senate Bill 1380 would eliminate prior authorization for a broad list of services, including emergency, primary, mental health, substance use, chemotherapy, preventive, pediatric hospice, and certain chronic-condition care. Physicians and hospice advocates supported the bill, describing delays, administrative burden, and patient harm, while health plans opposed blanket exemptions and argued prior authorization helps prevent unnecessary care and control costs. Relatedly, Senate Bill 547 would require insurers to report gold-card prior authorization exemptions to TDI and create a centralized database and annual report; TMA supported better tracking, while health plans warned of duplicative reporting and administrative cost. Senate Bill 407 would require health care facilities to honor conscience- and religion-based vaccine exemptions for employees, with testimony from a physician and vaccine-choice advocate supporting the bill. The committee also heard Senate Bill 1383, which would regulate senior living referral agencies, allow more flexible compensation structures, and add disclosure and consumer protections; an out-of-state referral company and A Place for Mom supported it. Senate Bill 1511 would allow freestanding emergency centers to provide outpatient services in addition to emergency care, with consumer protections such as estimates, limits on facility fees, and restrictions on balance billing. The chair repeatedly announced that bills were being left pending after testimony, and no final committee action or recorded votes were taken in the transcript provided.

Transcript Highlights:

• So after our passage, the Senate amendment, what it does is define essential services, FDA, and therapeutic
• It allows health plans to cover at least one FDA-approved therapeutic equivalent of PEP or PrEP medication
• , FDA-approved therapeutic equivalent of PEP or PrEP medication without cost sharing, prior authorization

Keywords: 1064, all

Transcript Highlights:

• Um, so I am here today to help ensure that we can have access to the newest FDA-approved emergency epinephrine
• The first one here is why we're here: it's the FDA approval of this nasal spray.
• The first one here is why we're here: it's the FDA approval of this nasal spray.

Keywords: 1189, house, all

Transcript Highlights:

• Making sure we're addressing FDA-approved diagnostics and treatments, making sure there's insurance coverage

Keywords: 1204, all

Transcript Highlights:

• which explains how over 90% of drugs that appear safe and effective in animals do not go on to receive FDA

Keywords: 995, all

Summary: The joint committee held a public hearing on several bills covering state administration, land/public housing redevelopment, construction safety, memorialization, records management, rural grant equity, and animal research. Testimony in support of H. 3329 described an inequity in the Governor’s Council reimbursement statute, which currently cuts off travel, meals, and lodging reimbursement after four terms; the witnesses argued this disproportionately burdens members from western Massachusetts and creates geographic and economic barriers to service. The Boston Housing Authority supported legislation for the Brighton/Faneuil Gardens area, saying it would allow a mixed-use redevelopment that replaces all existing public housing units one-for-one, adds new affordable housing, creates replacement rehearsal space for displaced musicians, and preserves prevailing wage standards. A major portion of the hearing focused on S. 2112, a construction safety bill. Suffolk Construction, Boston building trade representatives, and local inspectors testified that the measure would strengthen training, site safety standards, oversight of high-risk work, and enforcement, while helping protect workers and the public and improving retention and recruitment of inspectors. Witnesses said the bill would align Massachusetts more closely with higher safety standards in other states and build on lessons from past construction-related incidents. The committee also heard support for S. 2162, which would create a COVID-19 memorial; the witness emphasized the scale of pandemic deaths in Massachusetts and the educational value of public memorials. Other testimony addressed H. 3321, which would modernize records preservation for registers of deeds by reducing reliance on costly microfilm in an increasingly electronic system; the witness said current law is outdated and expensive. H. 3311, aimed at advancing equity for rural communities receiving state grants, drew support from town officials in Leyden and Ashfield, who said small towns lack staff for grant writing and should be evaluated more on need and regional impact, especially for climate and public safety projects. Finally, S. 2117, concerning animal research, was supported by an animal welfare advocate who urged prohibiting state funds for animal experiments and shifting to non-animal research methods. After the hearing concluded, the chairs noted that additional hearings and polling votes would follow, and the committee then adjourned.

Transcript Highlights:

• act in Title 46 relative to Medicaid coverage of certain medications, to acquire Medicaid coverage of FDA-approved

Bills: SCR12, HB221, HB509, HCR58, SB78, SB25, SB80, SB132, SB155, SB157, SB202, SB228, SB250, SB414, SB433, SB479, SB513, SCR9, SCR58, SB65, SB215, SB249, SB269, SB282, SB296, SB323, SB363, SB369, SB474, SB490, SB492, SB500, SB514, HCR32, HB17, HB41, HB73, HB223, HB244, HB759, HB906, HB966, HB1006, HB1009, HB1086, HB1107, HB1112, HB1215, HB1242, SB217, SB283, SB469, HB36, HB42, HB74, HB119, HB159, HB259, HB302, HB414, HB459, HB776, HB848, HB956, HB1017, HB1028, HB1095, SB208, SB312, SB382, SB389, HB210, HB258, HB359, HB368, HB468, HB552, HB732, HB784, HB870, HB953, HB1117, HB1236

Keywords: logging, recognition, John Keith, environment, safety, Mississippi River bridge, Trump Expressway, transportation, federal funding, Louisiana highways, injection wells, public hearing, geologic sequestration, environmental impact, public comment, Ascension Parish, state capitol, economic development, community partnership, celebration day

Transcript Highlights:

• At this point when it comes to the FDA, they meet the definition of cigarettes.

Transcript Highlights:

• FDA says we're not allowed; regulations say we're not allowed, but people still do it. That's it.

Keywords: 914, all

Transcript Highlights:

• non-controversial, science-backed idea, and again, I direct the Senator to the testimony from our own FDA

Bills: SB331

Keywords: fentanyl, controlled substances, drug trafficking, public health, research regulations, law enforcement, S-331, Halt All Lethal Trafficking and Fentanyl Act, fentanyl crisis, public testimony, drug legislation, bipartisan support

Summary: In this committee meeting, the focus was primarily on S-331, the Halt All Lethal Trafficking and Fentanyl Act, aimed at addressing the fentanyl crisis. The bill's key components include making permanent the class scheduling of fentanyl-related substances, confirming existing sentencing penalties, and easing registration requirements for scientific research on Schedule I substances. Numerous parents shared heartbreaking testimonies about their losses due to fentanyl, which fueled an urgent call to pass the legislation without alterations. The committee members engaged in passionate discussions highlighting the urgency of the situation as overdoses continue to claim American lives.

Transcript Highlights:

• VETERANS AFFAIRS NURSING HOME IN MY TENURE WE HAVE COMPLETED FIVE OF THOSE FOR THE FDA.

Keywords: 999, senate, all

Transcript Highlights:

• It is safe and thoroughly reviewed and regulated by both the USDA and FDA.
• the commissioner was going to be making rules, and so I'm just... you're deferring the rules that the FDA
• <01:36:51.920> rules<01:36:52.159> that<01:36:52.480> the<01:36:52.639> FDA
• you're deferring the rules that the FDA you're deferring the rules that the FDA is<01:36:53.520>

Keywords: 1187, senate, all

Transcript Highlights:

• We bring the meat to the labs, and, you know, they are still inspected meat; it's just not FDA.
• meat<00:07:59.919> it's<00:08:00.120> just<00:08:00.280> not<00:08:00.560> FDA
• <00:08:01.560> I<00:08:01.639> know inspected meat it's just not FDA I know inspected
• meat it's just not FDA I know uh<00:08:02.360> who<00:08:02.599> it<00:08:02.720> the
• So did I understand that you would still be state inspected but not subject to FDA inspection?

Keywords: 1191, senate, all

Transcript Highlights:

• I think you're referring to, like, stacking of the requirements: FDA-approved approval timeline, state
• workforce eligibility requirements, would they revoke the approval after it's already been granted by the FDA

Summary: The committee heard several bills, with SB 1350 by Senator McNerney presented first. The measure would expand California’s use of renewable hydrogen in the power sector by allowing renewable portfolio standard credit for power plants using green hydrogen, with supporters emphasizing grid reliability, clean-energy goals, in-state investment, and construction jobs. Support came from labor, clean-energy, municipal utility, and local government representatives; NRDC Action Fund withdrew opposition after amendments, while a few groups remained opposed or neutral. The committee later took a roll call and SB 1350 passed out on a due pass recommendation. The committee also heard SB 1180 by Senator Allen, which would set operational rules for the Plastic Pollution Mitigation Fund created under SB 54, including clearer eligible uses, transparency, technical assistance, and access for tribes and smaller community groups. Environmental justice, ocean, conservation, and local government groups strongly supported the bill, saying it would ensure the fund addresses plastic pollution’s public health and environmental harms. Industry and manufacturing groups opposed unless amended, arguing the bill should stay tightly tied to plastic waste reduction and not broaden into source-reduction policy. After quorum was established, the committee approved SB 1180 on a due pass recommendation to Appropriations. SB 1326 by Senator Wahab was then heard to strengthen tribal consultation and tribal cultural resource protections under CEQA by recognizing tribal registers and requiring feasible avoidance or mitigation measures when tribes identify resources. Tribal representatives and supporters said the bill would better protect sacred sites and tribal knowledge, while cities, counties, utilities, builders, and rural county groups opposed unless amended, citing implementation concerns, possible litigation, and uncertainty for infrastructure and housing projects. The committee voted the bill out on a due pass recommendation to Appropriations. Finally, SB 954 by Senator Blakespear was presented as a cleanup of last year’s SB 131 advanced-manufacturing CEQA exemption, narrowing eligible projects and adding guardrails such as setbacks, air-quality limits, tribal consultation, labor standards, and habitat protections. Environmental and labor groups supported the bill as a needed correction to an overly broad exemption, while business, manufacturing, housing, and local-government groups opposed, warning it could make the exemption unusable and slow investment. Members debated the balance between environmental protection and manufacturing competitiveness, and the committee voted SB 954 out on a due pass recommendation to the Labor and Employment Committee; the transcript then moved on to SB 1031 on compostable plastics, which was introduced but not acted on in the portion provided.

Transcript Highlights:

• In that same month, just June 2025, the FDA approved the most powerful PrEP medication we have to date
• The recently FDA-approved Yeztugo, a twice-yearly injectable PrEP, is a major advancement in HIV prevention

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a public hearing on a wide range of bills, with testimony first focused on H. 1315/S. 824, which would require insurance coverage for pain management options during IUD insertion. Representative Sabadosa, Planned Parenthood clinicians, and policy advocates said sedation can reduce fear and trauma, improve access to effective contraception, and should be reimbursed so providers can continue offering it. A Tufts OB-GYN resident also testified that pain control should be standard care for intrauterine procedures. No votes were taken during the hearing. The committee then heard extensive testimony on firefighter health bills, especially H. 1230/S. 690 requiring insurance coverage for cancer screenings for firefighters. Professional Fire Fighters of Massachusetts leaders, a Dana-Farber oncologist, and firefighters themselves described occupational exposure to carcinogens and personal stories of late-stage cancer detection, arguing that early screening can save lives and reduce long-term costs. Representative Crichton and Representative Howitt also spoke in support, and Representative Ayers testified for H. 4012, which would require neurological disorder screenings for firefighters. Committee members expressed support and sympathy, but no action was taken. The hearing also covered H. 3946/S. 756 on hearing aid coverage, with testimony from students, adults with hearing loss, disability advocates, and HLAA representatives describing the educational, social, and financial barriers caused by lack of coverage and urging broader insurance mandates. Later, Representative Donahue and Representative Vargas testified for H. 1337 to expand insurance coverage for opioid antagonists and related medications, including naloxone dispensed at discharge. The committee additionally heard testimony on H. 1134 to improve chronic pain care coordination and non-opioid access, and H. 4162 to improve ostomy supply coverage and access to certified ostomy care, with patients and clinicians describing denials, quantity limits, and non-medical switching. The transcript ends while testimony on H. 1315/S. 824 is still ongoing; no votes or formal committee actions are recorded in the excerpt.

Transcript Highlights:

• So my understanding with pharmacy and pharmaceutical drugs is that isn't there like an FDA requirement
• So for SB 2038, huge concern about labeling, FDA requirements, cost.

Keywords: 912, senate, all

Summary: The HHS committee met in Room 224 and announced the hearing was being streamed live, with a one-minute limit on testimony. The chair explained that written testimony had already been reviewed and that speakers should either add new comments or stand on their written testimony. The committee first heard SB 2211, an emergency appropriation to the Department of Human Services. Testimony was overwhelmingly in support, including DHS, Aloha United Way, the Hawaii Food Industry Association, the Hawaii Public Health Institute, Catholic Charities, and many individuals. Supporters emphasized the importance of maintaining SNAP-related food assistance and emergency food delivery, while Catholic Charities raised a question about whether the bill’s language would also reach food banks serving food-insecure households that are not on SNAP. No opposition was heard and the bill was moved on without questions from members. The committee then heard SB 2025, which would exempt actively practicing advanced practice registered nurses from jury duty. Testimony was broadly supportive from nursing and health organizations, including the Hawaii American Nurses Association, the Hawaii affiliate of the College of Nurse Midwives, the Hawaii State Board of Nursing, and others. One witness from Kaiser Permanente requested an amendment to include physician assistants, and a committee member asked the Board of Nursing to review that request. The bill otherwise drew no opposition and no further member questions. SB 2038, relating to medication labeling, drew the most extended discussion. The measure would change labeling requirements for certain abortion medications, and testimony was split between supporters who framed it as a privacy and access issue and opponents who raised patient safety, ethics, and transparency concerns. The Department of Health supported the intent but requested an amendment to allow quicker access to private information during investigations without a subpoena. The Board of Pharmacy said it supported the written comments but noted operational challenges and possible cost impacts, while Kaiser said compliance would likely require manual workarounds and could slow pharmacy processes. The chair and members questioned whether patients could simply remove labels themselves, but witnesses said there could still be safety and access issues if the patient is not the one receiving the prescription. The committee then moved on to SB 2050, relating to chiropractic, which received support from the Hawaii Board of Chiropractic and the Hawaii State Chiropractic Association, with no substantive opposition noted. The hearing later turned to SB 201, relating to insurance, which appeared to be a new mandated-benefit measure tied to infertility/IVF coverage. The Hawaii Civil Rights Commission provided comments, while Hawaii Family Forum opposed the bill, arguing it went beyond medical infertility and raised ethical and public policy concerns. Kaiser and the Hawaii Association of Health Plans both asked for a study or audit, saying the measure could create new insurance mandates and increase costs for residents and employers. Private Work Hawaii strongly supported the bill as an equity issue. The committee noted there was no quorum for decision-making and deferred action on the measure to a later hearing, then recessed.